Contact

Please select a country

us@pharmalex.com

Contact United States

TwitterLinkedin
contact@pharmalex.com
Search
PharmaLexPharmaLex
PharmaLex
Confidence Beyond Compliance
  • About Us
    • About Us
    • Management Team
    • Industry Expertise
      • Biopharma
      • Customer On-site Support
      • Medical Device Services
      • Portfolio Maintenance Outsourcing
    • What Our Clients Say About Us
    • Our Approach
    • Resource Library
  • Our Services
    • Choose a Service
    • InnoPHLEX
    • SourcePHLEX
    • Development Consulting
    • Regulatory Affairs
    • Quality Management & Compliance
    • Pharmacovigilance, Epidemiology & Risk Management
    • Medical Device Services
    • Brexit
  • News & Events
    • News
    • Webinars
    • Events
  • Countries
  • Contact us
  • Careers
    • Current Opportunities
    • Why work at PharmaLex
    • Working at PharmaLex
Menu back  
Home > News & Events > Global > PharmaLex Group builds US presence with acquisition of Safis Solutions

PharmaLex Group builds US presence with acquisition of Safis Solutions

The merger demonstrates PharmaLex’s commitment to the US market and complements its existing EU medical device expertise

Friedrichsdorf / Indianapolis, IN, April 21st 2017: As of 7th April, 2017, the PharmaLex Group, a leading specialist provider of development consulting and scientific affairs, regulatory affairs and pharmacovigilance, has completed the formal merger of Safis Solutions.

Safis Solutions is headquartered in Indianapolis, IN, USA. Founded in 2002, the company specializes in regulatory affairs, having a particular strength in medical devices. Working with companies in the regulated life science industry, Safis Solutions provides expertise in medical products regulatory registration and market clearance consulting, as well as regulatory compliance, quality systems, validation and auditing services.

“The acquisition enables PharmaLex to complement its existing EU medical device expertise with high quality and established US medical device capabilities”, explained Dr. Thomas Dobmeyer, CEO PharmaLex. “It will help establish us as a key provider in the US”, he continued. Dr. Tilo Netzer, CEO PharmaLex, added, “The provision of this additional regulatory experience will help support making us a partner of choice for global medical device and combination product projects. It is further evidence of the importance we are placing on our US business”. “We are delighted to be joining the PharmaLex Group” said Ping Poulsen, Founder, Safis Solutions. “Not only can we expand our breadth and depth of expertise by being part of a global multi-national company, but a more mature infrastructure will allow us to offer our clients a more comprehensive service portfolio”, she added.

The PharmaLex Group now has over 550 employees, with 23 offices in 12 countries and more than 600 satisfied clients worldwide.

-Ends-

About PharmaLex <Confidence beyond compliance>:
PharmaLex combines local expertise with global reach in the area of development consulting and scientific services, regulatory affairs and pharmacovigilance. A proven track record of success in outsourcing programs, more than 25,000 successfully completed projects for over 600 clients worldwide, as well as extensive experience in all therapeutic areas and product groups, including advanced therapy medicinal products and biopharmaceuticals, medical and borderline products and alternative therapeutic approaches.

For further information, please contact:
Ms. Eva Keck
Director Business Development Operations, PharmaLex GmbH
eva.keck@pharmalex.com
+49 621 18 15 38 0
Harrlachweg 6; 68163 Mannheim,
Germany

About PharmaLex
Related posts
Top 10 Tips for an effective Internal Audit System
20th February 2019
Use and Learn Period for Serialisation
14th February 2019
Cleaning Validation
13th February 2019
Brexit: Update for the Pharma Industry
7th February 2019
How can you add value to your Self-Inspection Programme?
30th January 2019
Webinar // Early Phase Modelling – Estimating the Costs and Effectiveness of a Pharmaceutical before Clinical Trial
25th January 2019
Search
Recent News
  • Top 10 Tips for an effective Internal Audit System
    20th February 2019
  • Use and Learn Period for Serialisation
    14th February 2019
  • Cleaning Validation
    13th February 2019
  • Brexit: Update for the Pharma Industry
    7th February 2019
  • How can you add value to your Self-Inspection Programme?
    30th January 2019
  • Webinar // Early Phase Modelling – Estimating the Costs and Effectiveness of a Pharmaceutical before Clinical Trial
    25th January 2019
Categories
  • All News
  • Webinars
  • Events
Archive
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
  • Will you be at DIA RSIDM 2019 in North Bethesda? If you are, make sure you stop by our booth and say hello.… https://t.co/tMVDOLWmw523 days ago
  • Take part in our survey on pharmaceutical serialization. It only takes a few minutes and helps us identify some of… https://t.co/bw1DQP5N3223 days ago
NEWSLETTER SIGN UP










View our privacy policy

WHAT OUR CLIENTS SAY
  • PharmaLex is dedicated to delivering a comprehensive portfolio while their modular approach allows tailor-made solutions. They acknowledge our feedback, modify their approach and adapt accordingly.

    Top 10 Pharma Company
    President
PharmaLex
©2018 PharmaLex GmbH. All rights reserved.

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. These emails are being sent from @pharmalexcompanies.com and are not from us. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.

Privacy Policy

This can be specific information about signing up to the newsletter.

Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.